Research shows an improved chance of surviving ICU when patients are cared for in units with more than 75% qualified ICU nursing staff, but there’s a desperate shortage of them.
New research shows the ongoing effects from critical illness with COVID-19 can be long and serious.
A lot has changed in COVID treatment since the pandemic began. Here are the treatments you can expect — from being diagnosed, to going to hospital, and for those who need to be cared for in ICU.
Does it matter that NSW Premier Gladys Berejiklian has stopped having daily media briefings?
Australia’s COVID-19 vaccine rollout priority should move from those most at risk of the disease to those most likely to spread it, according to new modelling.
Scientists are well-advanced in mapping the way forward to develop and repurpose medicines for respiratory virus patients in the post-COVID era.
Although it was a century ago, there are parallels between the Spanish Flu pandemic and COVID-19. What was it like on the frontline for our healthcare workers this time around – and what have we learnt as a society?
Recruiting people for clinical trials is a major challenge, and an obstacle to success, but there are strategies researchers can use to improve outcomes.
New research aims to reveal the post-ICU effects on the body, and will highlight the vital role of physiotherapists in intensive care.
What will help people stick to the rules is clear communication from authorities about the restrictions, and consistent messaging.
Multicultural leaders say it's vital to involve their communities in COVID-19 response strategies, tailor messaging to community values, and choose trusted messengers to deliver it.
Work placements put Monash University medicine and pharmacy students on the COVID-19 frontline.
While we've so far successfully contained COVID-19, the modelling clearly shows now isn't the time to relax many of the restrictions.
Mechanical ventilation is saving lives during the COVID-19 pandemic, but it can also harm the lungs.
Researchers have repurposed existing tools to make a COVID-19 immunity test breakthrough.
Rather than basing decisions about ICU access on age, clinicians need to consider the potential benefits and burdens of treatments proposed for every patient.
Critically ill patients from intensive care units are part of a global trial testing a suite of flu and pneumonia drugs in a bid to combat COVID-19.
Associate Professor John Boyce is part of an international team about to begin a new five-year investigation into the superbug, its antibiotic-resistance mechanisms, and also novel (new) treatments for infection.
Dummy text
